The efficacy of omarigliptin in type 2 diabetic patients
Not Applicable
- Conditions
- Type2 diabetes mellitus
- Registration Number
- JPRN-UMIN000026700
- Lead Sponsor
- Kawashima Hospital, Social Medical Corporation Kawashima Hospital Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 41
Inclusion Criteria
Not provided
Exclusion Criteria
Patients having infectious diseases, thyroid disease, or malignant tumors. Patients being treated with steroids and changing the dosage. Patients considering not eligible for this trial by attending doctors due to any medical reasons.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method